Effects of combination lipid therapy in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Tonkin
Andrew M
AM
Cardiovascular Research Unit, Department of Epidemiology and Preventive Medicine, Monash University, 99 Commercial Rd, Melbourne, Victoria 3004, Australia. Andrew.Tonkin@monash.edu
Chen
Lei
L
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D004359:Drug Therapy, Combination; D011345:Fenofibrate / Q000008:administration & dosage*; D006801:Humans; D008055:Lipids / Q000097:blood; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D019821:Simvastatin / Q000008:administration & dosage*
D008076:Cholesterol, HDL; D008055:Lipids; D019821:Simvastatin; D011345:Fenofibrate